PDGFRA and glioblastoma: Alterations identified by Titan-CNA in the 4q12 MCR covered recognized oncogenes and genes with known biological significance in glioma and glioblastoma, including PDGFRA, REST, and CLOCK9,23,24 (Figure 2F box).